Ferrohematogen^® (Pastilles) Instructions for Use

Marketing Authorization Holder

Pharmstandard-UfaVITA OJSC (Russia)

Manufactured By

Pharmstandard-Lexredstva OJSC (Russia)

ATC Code

B03AE10 (Iron preparations in combination with other drugs)

Dosage Form

Ferrohematogen^®

Chewable lozenges: 50 g

Dosage Form, Packaging, and Composition

Chewable lozenges brown or dark brown in color, divided into segments, with a predominant vanilla aroma.

	1 lozenge (50 g)
Food grade black albumin	2.375 g
Ascorbic acid (vit. C)	50 mg
Pyridoxine hydrochloride (vit. B₆)	2 mg
Folic acid	100 mcg
Iron (in the form of heptahydrate sulfate)	5 mg
Copper (in the form of pentahydrate sulfate)	250 mcg

Excipients: whole sweetened condensed milk, starch molasses, sucrose (sugar), vanillin – to obtain a lozenge weighing 50 g.

1 lozenge (50 g) – wrapper made of film material.

Clinical-Pharmacological Group

Antianemic drug. Vitamin complex with a trace element

Pharmacotherapeutic Group

Iron preparation + other preparations

Pharmacological Action

A combined drug. It replenishes the deficiency of iron, which is necessary for the body’s vital functions.

Iron is part of hemoglobin, myoglobin, and various enzymes. Reversibly binding oxygen, it participates in a number of redox reactions and stimulates erythropoiesis.

Copper sulfate, ascorbic and folic acids, and pyridoxine hydrochloride contribute to more active absorption of iron, its entry into the systemic bloodstream, and lead to the restoration of its normal concentration in the body.

Food albumin, condensed milk, and sugar allow the drug to be used as a dietary supplement for insufficient nutrition.

Indications

Latent iron deficiency (without anemia): inadequate nutrition; period of active growth; chronic gastritis (hypo- and anacid gastritis); pregnancy; lactation period; convalescence (after somatic and infectious diseases); activities associated with significant neuropsychic and physical stress.

ICD codes

Open the list of ICD codes

ICD-10 code	Indication
E61.1	Iron deficiency
E63.1	Disparate intake of food elements
O25	Nutritional deficiencies in pregnancy
Z54	Convalescence
Z73.0	Burn-out
Z73.3	Stress, not elsewhere classified (physical and mental strain)

ICD-11 code	Indication
5B5K.0	Iron deficiency
5B7Z	Malnutrition, unspecified
JA64	Nutritional disorders during pregnancy
QB7Z	Convalescence, unspecified
QD85	Burn-out
QE01	Stress, not elsewhere classified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Administer orally.

For general supplementation: take 1 to 2 lozengestwo to three times daily.

Continue this regimen for a duration of 1 to 2 months.

For maintenance therapy following iron deficiency anemia: take 2 lozenges once daily.

Chew the lozenge thoroughly before swallowing.

Adhere strictly to the recommended dosage and duration of use.

Adverse Reactions

Allergic reactions.

Contraindications

Hypersensitivity; increased iron content in the body (hemosiderosis, hemochromatosis); impaired iron utilization (aplastic anemia, hemolytic anemia); megaloblastic B₁₂-deficiency anemia.

Use in Pregnancy and Lactation

Use is possible according to the dosing regimen.

Drug Interactions

Reduces the absorption of tetracyclines, penicillamine.

Simultaneous use of antacids and parenteral iron preparations is not recommended.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer